FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2520342023> ?p ?o ?g. }

• W2520342023 endingPage "728" @default.
• W2520342023 startingPage "716" @default.
• W2520342023 abstract "Background: The objective of the FLIGHT3 study was to evaluate the long-term safety and efficacy of indacaterol/glycopyrrolate* (IND/GLY) versus an active comparator, IND, in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) over 52 weeks. Method: FLIGHT3 was a multicenter, randomized, double-blind, parallel-group, 52-week study. Patients were randomized (1:1:1) to IND/GLY (27.5/15.6 or 27.5/31.2 µg twice daily [b.i.d.]) or IND (75 µg once daily [o.d.]), delivered via the Neohaler® device. The primary objective was to evaluate the long-term safety and tolerability of IND/GLY versus IND in terms of adverse event (AE)-reporting rates in patients with moderate-to-severe COPD over 52 weeks. The secondary objective was to evaluate the long-term efficacy of IND/GLY versus IND in terms of pre-dose trough forced expiratory volume in 1 second (FEV1) and post-dose 1-h FEV1 over 52 weeks. Results: A total of 85.2% patients completed the study treatment. The overall incidence of AEs (and SAEs) was similar between treatments. Major adverse cardiovascular events (MACE) and/or cardiovascular (CV) events were comparable between treatment groups. The rate of discontinuation of the study treatment due to AEs was lower for IND/GLY than IND. Improvements in pre-dose trough FEV1 and post-dose 1-h FEV1 were consistently superior with IND/GLY than with IND over 52 weeks, demonstrating long-term maintenance of lung function. Conclusions: IND/GLY demonstrated a favorable long-term safety and tolerability profile and provided effective bronchodilation, with maintenance of lung function over 52 weeks in patients with moderate-to-severe COPD. These data support the safety and efficacy of IND/GLY as a treatment option for COPD. Trial registration: ClinTrials.gov identifier NCT01682863 *Glycopyrrolate 15.6 µg (excluding the bromide salt) is equivalent to 12.5 µg glycopyrronium." @default.
• W2520342023 created "2016-09-23" @default.
• W2520342023 creator A5046225712 @default.
• W2520342023 creator A5052626090 @default.
• W2520342023 creator A5054694856 @default.
• W2520342023 creator A5064858768 @default.
• W2520342023 creator A5070315113 @default.
• W2520342023 creator A5085245138 @default.
• W2520342023 creator A5087106144 @default.
• W2520342023 date "2016-01-01" @default.
• W2520342023 modified "2023-09-23" @default.
• W2520342023 title "Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study" @default.
• W2520342023 cites W1481550704 @default.
• W2520342023 cites W1627527233 @default.
• W2520342023 cites W1950043623 @default.
• W2520342023 cites W1980016322 @default.
• W2520342023 cites W1980789906 @default.
• W2520342023 cites W2003293665 @default.
• W2520342023 cites W2021047838 @default.
• W2520342023 cites W2032171019 @default.
• W2520342023 cites W2032257275 @default.
• W2520342023 cites W2064720111 @default.
• W2520342023 cites W2075195662 @default.
• W2520342023 cites W2079698487 @default.
• W2520342023 cites W2089834473 @default.
• W2520342023 cites W2118093436 @default.
• W2520342023 cites W2122297255 @default.
• W2520342023 cites W2130890836 @default.
• W2520342023 cites W2134091333 @default.
• W2520342023 cites W2136872827 @default.
• W2520342023 cites W2142449488 @default.
• W2520342023 cites W2158795682 @default.
• W2520342023 cites W2160609432 @default.
• W2520342023 cites W2163053179 @default.
• W2520342023 cites W2169393211 @default.
• W2520342023 cites W2169957722 @default.
• W2520342023 cites W2171974515 @default.
• W2520342023 cites W2412632232 @default.
• W2520342023 cites W4292405041 @default.
• W2520342023 doi "https://doi.org/10.15326/jcopdf.3.4.2016.0131" @default.
• W2520342023 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5556955" @default.
• W2520342023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28848898" @default.
• W2520342023 hasPublicationYear "2016" @default.
• W2520342023 type Work @default.
• W2520342023 sameAs 2520342023 @default.
• W2520342023 citedByCount "8" @default.
• W2520342023 countsByYear W25203420232018 @default.
• W2520342023 countsByYear W25203420232020 @default.
• W2520342023 countsByYear W25203420232021 @default.
• W2520342023 countsByYear W25203420232022 @default.
• W2520342023 crossrefType "journal-article" @default.
• W2520342023 hasAuthorship W2520342023A5046225712 @default.
• W2520342023 hasAuthorship W2520342023A5052626090 @default.
• W2520342023 hasAuthorship W2520342023A5054694856 @default.
• W2520342023 hasAuthorship W2520342023A5064858768 @default.
• W2520342023 hasAuthorship W2520342023A5070315113 @default.
• W2520342023 hasAuthorship W2520342023A5085245138 @default.
• W2520342023 hasAuthorship W2520342023A5087106144 @default.
• W2520342023 hasBestOaLocation W25203420231 @default.
• W2520342023 hasConcept C126322002 @default.
• W2520342023 hasConcept C168563851 @default.
• W2520342023 hasConcept C197934379 @default.
• W2520342023 hasConcept C2776780178 @default.
• W2520342023 hasConcept C2777714996 @default.
• W2520342023 hasConcept C2778375690 @default.
• W2520342023 hasConcept C2778715236 @default.
• W2520342023 hasConcept C2778884479 @default.
• W2520342023 hasConcept C2780739214 @default.
• W2520342023 hasConcept C3018587741 @default.
• W2520342023 hasConcept C42219234 @default.
• W2520342023 hasConcept C45393284 @default.
• W2520342023 hasConcept C500558357 @default.
• W2520342023 hasConcept C71924100 @default.
• W2520342023 hasConceptScore W2520342023C126322002 @default.
• W2520342023 hasConceptScore W2520342023C168563851 @default.
• W2520342023 hasConceptScore W2520342023C197934379 @default.
• W2520342023 hasConceptScore W2520342023C2776780178 @default.
• W2520342023 hasConceptScore W2520342023C2777714996 @default.
• W2520342023 hasConceptScore W2520342023C2778375690 @default.
• W2520342023 hasConceptScore W2520342023C2778715236 @default.
• W2520342023 hasConceptScore W2520342023C2778884479 @default.
• W2520342023 hasConceptScore W2520342023C2780739214 @default.
• W2520342023 hasConceptScore W2520342023C3018587741 @default.
• W2520342023 hasConceptScore W2520342023C42219234 @default.
• W2520342023 hasConceptScore W2520342023C45393284 @default.
• W2520342023 hasConceptScore W2520342023C500558357 @default.
• W2520342023 hasConceptScore W2520342023C71924100 @default.
• W2520342023 hasIssue "4" @default.
• W2520342023 hasLocation W25203420231 @default.
• W2520342023 hasLocation W25203420232 @default.
• W2520342023 hasLocation W25203420233 @default.
• W2520342023 hasLocation W25203420234 @default.
• W2520342023 hasOpenAccess W2520342023 @default.
• W2520342023 hasPrimaryLocation W25203420231 @default.
• W2520342023 hasRelatedWork W1522553747 @default.
• W2520342023 hasRelatedWork W2024631328 @default.
• W2520342023 hasRelatedWork W2059313976 @default.
• W2520342023 hasRelatedWork W2089245388 @default.

• next